Osimertinib in Elderly Patients with Epidermal Growth Factor Receptor T790M-Positive Non-Small-Cell Lung Cancer Who Progressed During Prior Treatment: A Phase II Trial.

Osimertinib in Elderly Patients with Epidermal Growth Factor Receptor T790M-Positive Non-Small-Cell Lung Cancer Who Progressed During Prior Treatment: A Phase II Trial. — المؤلف: Nakao, Akira — The oncologist 20200511

المؤلف
Nakao, Akira
النشر
The oncologist 20200511
الوصف
593-e170 p.
الموضوعات
Acrylamides؛ Aged؛ Aniline Compounds؛ Antineoplastic Agents؛ Carcinoma, Non-Small-Cell Lung؛ Disease Progression؛ ErbB Receptors؛ Female